Oxford’s Journal of Public Well being has the most recent version of the Medi-Weightloss Research on Metabolic Syndrome

By: | 0 shares 65 reads

Landmark Clinical Research Introduced as Editor’s Choice and Cover Story in the December 2020 issue

March 09, 2021 // // TAMPA, Florida – Medi-Weightloss, a proven franchise weight loss program with a clinical approach, has published its study results on the prevalence of Metabolic Syndrome in the highly regarded Editor’s Choice of the Journal of Public Health . It was also featured on the cover of the issue.

The Oxford Journal of Public Health is one of the university’s oldest publications dating back to 1892. It is a quarterly peer-reviewed journal covering a range of health-related topics related to public health research and practice by researchers, scholars and scientists Clinicians from all over the world have been submitted to the world. In its most recent edition, Medi-Weightloss’s study of weight loss and metabolic syndrome prevalence received multiple awards for cutting-edge research sponsored by the company.

Despite the fact that more than a third of the world’s population suffers from metabolic syndrome, the issue has long been overlooked and rarely discussed in public or in the clinical setting. The purpose of the Medi-Weightloss study was to identify the prevalence of metabolic syndrome in the patient population and its change over the course of their weight loss journeys. The results of his study showed that metabolic syndrome is less common in patients as they lose weight with Medi-Weightloss.

“This study confirms previous research suggesting that lifestyle choices and patient management are essential components of success in efforts to address metabolic syndrome risk factors and help patients lose weight effectively,” said Macklin Guzman, DHSc, MPH, Chief Science Officer for Medi-Weightloss. “It is noteworthy that our research and results were published as the editor’s choice in the Journal of Public Health and are evidence of its importance.”

Reducing obesity is a top priority for individuals due to concerns related to COVID-19. People with metabolic syndrome and / or obesity are at greater risk of complications and worsened symptoms than people without metabolic syndrome and / or obesity. According to recent research on the subject, around 56% of patients with metabolic syndrome end up in the intensive care unit, while only 24% of patients without metabolic syndrome do so. It has also been found that people with metabolic syndrome are almost four times more likely to die when they contract COVID.

“More than ever, we are proud to continue to offer our patients a program that is not only evidence-based but has also been clinically proven to be an effective treatment for metabolic syndrome and its obesity-related components. Our health care providers work hand in hand with our patients and their primary care providers to improve their overall health and further reduce their risk of developing chronic diseases from weight loss, ”said Dr. Gretchen San Miguel, Chief Medical Officer of Medi- Weight Loss.

SOURCE Medi-Weightloss®



Comments powered by

Related Articles